Edition:
United States

Theravance Biopharma Inc (TBPH.OQ)

TBPH.OQ on NASDAQ Stock Exchange Global Market

22.06USD
20 Apr 2018
Change (% chg)

$-0.12 (-0.54%)
Prev Close
$22.18
Open
$21.93
Day's High
$22.15
Day's Low
$21.27
Volume
78,744
Avg. Vol
75,991
52-wk High
$43.30
52-wk Low
$21.27

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Hold -1.15 December 23 Apr 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 4 3 3 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 2 2 2 2
(5) SELL 1 1 1 1
No Opinion 0 0 0 0
Mean Rating 2.75 2.86 2.86 2.86

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 7 11.42 25.00 5.10 10.00
Quarter Ending Sep-18 7 18.58 31.90 6.50 12.00
Year Ending Dec-18 7 51.56 67.90 40.00 62.59
Year Ending Dec-19 7 91.43 119.40 64.91 82.45
Earnings (per share)
Quarter Ending Jun-18 7 -1.15 -0.87 -1.50 -1.25
Quarter Ending Sep-18 7 -1.04 -0.81 -1.31 -1.28
Year Ending Dec-18 7 -4.46 -3.72 -5.04 -4.06
Year Ending Dec-19 7 -3.87 -3.07 -5.10 -3.83

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Dec-17 4.84 4.51 0.33 6.77
Quarter Ending Sep-17 4.61 4.28 0.33 7.22
Quarter Ending Jun-17 4.66 3.51 1.15 24.74
Quarter Ending Mar-17 5.57 3.09 2.49 44.62
Quarter Ending Dec-16 4.90 5.69 0.79 16.18

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jun-18 11.42 11.42 9.15 5.93 10.00
Quarter Ending Sep-18 18.58 18.58 20.59 6.91 12.00
Year Ending Dec-18 51.56 51.56 53.49 57.65 62.59
Year Ending Dec-19 91.43 91.43 90.00 67.20 82.45

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-18 0 0 0 0
Quarter Ending Sep-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings